Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes

Michele Di Perna, Eirini Louizou, Lucia Fischetti, G. V Z Dedoussis, Pietro Stanziale, Helen Michelakakis, Leopoldo Zelante, Elon Pras, Luigi Bisceglia

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Mutations in the SLC3A1 and SLC7A9 genes cause cystinuria (OMIM 220100), an autosomal recessive disorder of amino acid transport and reabsorption in the proximal renal tubule and in the epithelial cells of the gastrointestinal tract. In an attempt to characterize the molecular defect in the SLC3A1 and SLC7A9 genes, we analyzed a cohort of 85 unrelated subjects clinically diagnosed as affected by cystinuria on the basis of stone formation, prevalently of Italian and Greek origin. Analysis of all coding region and exon-intron junctions of the SLC3A1 and SLC7A9 genes by using direct sequencing method allowed us to identify 62 different mutations in 83 out of 85 patients accounting for 90.5% of all affected chromosomes. Twenty-four out of 62 are novel mutations, 9 in SLC3A1 and 15 in SLC7A9. In conclusion, this report expands the spectrum of SLC3A1 and SLC7A9 mutations and confirms the heterogeneity of this disorder.

Original languageEnglish
Pages (from-to)351-355
Number of pages5
JournalGenetic Testing
Volume12
Issue number3
DOIs
Publication statusPublished - Sep 1 2008

Fingerprint

Cystinuria
Mutation
Genes
Genetic Databases
Proximal Kidney Tubule
Introns
Gastrointestinal Tract
Exons
Chromosomes
Epithelial Cells
Amino Acids

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes. / Di Perna, Michele; Louizou, Eirini; Fischetti, Lucia; Dedoussis, G. V Z; Stanziale, Pietro; Michelakakis, Helen; Zelante, Leopoldo; Pras, Elon; Bisceglia, Luigi.

In: Genetic Testing, Vol. 12, No. 3, 01.09.2008, p. 351-355.

Research output: Contribution to journalArticle

Di Perna, M, Louizou, E, Fischetti, L, Dedoussis, GVZ, Stanziale, P, Michelakakis, H, Zelante, L, Pras, E & Bisceglia, L 2008, 'Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes', Genetic Testing, vol. 12, no. 3, pp. 351-355. https://doi.org/10.1089/gte.2007.0113
Di Perna, Michele ; Louizou, Eirini ; Fischetti, Lucia ; Dedoussis, G. V Z ; Stanziale, Pietro ; Michelakakis, Helen ; Zelante, Leopoldo ; Pras, Elon ; Bisceglia, Luigi. / Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes. In: Genetic Testing. 2008 ; Vol. 12, No. 3. pp. 351-355.
@article{488f3334d7974115b6e2e270f920268d,
title = "Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes",
abstract = "Mutations in the SLC3A1 and SLC7A9 genes cause cystinuria (OMIM 220100), an autosomal recessive disorder of amino acid transport and reabsorption in the proximal renal tubule and in the epithelial cells of the gastrointestinal tract. In an attempt to characterize the molecular defect in the SLC3A1 and SLC7A9 genes, we analyzed a cohort of 85 unrelated subjects clinically diagnosed as affected by cystinuria on the basis of stone formation, prevalently of Italian and Greek origin. Analysis of all coding region and exon-intron junctions of the SLC3A1 and SLC7A9 genes by using direct sequencing method allowed us to identify 62 different mutations in 83 out of 85 patients accounting for 90.5{\%} of all affected chromosomes. Twenty-four out of 62 are novel mutations, 9 in SLC3A1 and 15 in SLC7A9. In conclusion, this report expands the spectrum of SLC3A1 and SLC7A9 mutations and confirms the heterogeneity of this disorder.",
author = "{Di Perna}, Michele and Eirini Louizou and Lucia Fischetti and Dedoussis, {G. V Z} and Pietro Stanziale and Helen Michelakakis and Leopoldo Zelante and Elon Pras and Luigi Bisceglia",
year = "2008",
month = "9",
day = "1",
doi = "10.1089/gte.2007.0113",
language = "English",
volume = "12",
pages = "351--355",
journal = "Genetic Testing",
issn = "1090-6576",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes

AU - Di Perna, Michele

AU - Louizou, Eirini

AU - Fischetti, Lucia

AU - Dedoussis, G. V Z

AU - Stanziale, Pietro

AU - Michelakakis, Helen

AU - Zelante, Leopoldo

AU - Pras, Elon

AU - Bisceglia, Luigi

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Mutations in the SLC3A1 and SLC7A9 genes cause cystinuria (OMIM 220100), an autosomal recessive disorder of amino acid transport and reabsorption in the proximal renal tubule and in the epithelial cells of the gastrointestinal tract. In an attempt to characterize the molecular defect in the SLC3A1 and SLC7A9 genes, we analyzed a cohort of 85 unrelated subjects clinically diagnosed as affected by cystinuria on the basis of stone formation, prevalently of Italian and Greek origin. Analysis of all coding region and exon-intron junctions of the SLC3A1 and SLC7A9 genes by using direct sequencing method allowed us to identify 62 different mutations in 83 out of 85 patients accounting for 90.5% of all affected chromosomes. Twenty-four out of 62 are novel mutations, 9 in SLC3A1 and 15 in SLC7A9. In conclusion, this report expands the spectrum of SLC3A1 and SLC7A9 mutations and confirms the heterogeneity of this disorder.

AB - Mutations in the SLC3A1 and SLC7A9 genes cause cystinuria (OMIM 220100), an autosomal recessive disorder of amino acid transport and reabsorption in the proximal renal tubule and in the epithelial cells of the gastrointestinal tract. In an attempt to characterize the molecular defect in the SLC3A1 and SLC7A9 genes, we analyzed a cohort of 85 unrelated subjects clinically diagnosed as affected by cystinuria on the basis of stone formation, prevalently of Italian and Greek origin. Analysis of all coding region and exon-intron junctions of the SLC3A1 and SLC7A9 genes by using direct sequencing method allowed us to identify 62 different mutations in 83 out of 85 patients accounting for 90.5% of all affected chromosomes. Twenty-four out of 62 are novel mutations, 9 in SLC3A1 and 15 in SLC7A9. In conclusion, this report expands the spectrum of SLC3A1 and SLC7A9 mutations and confirms the heterogeneity of this disorder.

UR - http://www.scopus.com/inward/record.url?scp=50649084766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50649084766&partnerID=8YFLogxK

U2 - 10.1089/gte.2007.0113

DO - 10.1089/gte.2007.0113

M3 - Article

VL - 12

SP - 351

EP - 355

JO - Genetic Testing

JF - Genetic Testing

SN - 1090-6576

IS - 3

ER -